Postoperative pain management: Can transdermal patches help?

Orthopedics

Volumn 29, Issue 3, 2006, Pages 217-220

  Ball, Amanda M ^a   Smith, Kelly M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; BUPRENORPHINE; CLONIDINE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENTANYL; GLYCERYL TRINITRATE; ISOFLURANE; KETAMINE; LIDOCAINE; MORPHINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SCOPOLAMINE; SUFENTANIL; TRAMADOL;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ANALGESIC ACTIVITY; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DIZZINESS; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG EXPOSURE; DRUG INTERMITTENT THERAPY; DRUG POTENTIATION; DRUG SAFETY; HEADACHE; HIP SURGERY; HUMAN; HYPOVENTILATION; KNEE ARTHROPLASTY; LOW DRUG DOSE; MYDRIASIS; NAUSEA; ORTHOPEDIC SURGERY; ORTHOSTATIC HYPOTENSION; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; TRANSDERMAL PATCH; URINE RETENTION; VOMITING; XEROSTOMIA;

EID: 33644891891     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20060301-13     Document Type: Article

References (26)

1. Bonica JJ. The Management of Pain. Vol 1. 2nd ed. Philadelphia, Pa: Lea Febinger; 1990.
2. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologist Task Force on Acute Pain Management. Anesthesiology. 2004; 100:1573-1581.
3. Duragesic (fentanyl transdermal) [package insert]. Titusville, NJ: Janssen Pharmaceutica Products LP; 2005.
4. Caplan RA, Ready LB, Oden RV, Matsen FA III, Nessly ML, Olsson GL. Transdermal fentanyl for postoperative pain management. A double-blind placebo study. JAMA. 1989; 261:1036-1039.
5. Sevarino FB, Paige D, Sinatra RS, Silverman DG. Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermai opioid preparation affect analgesic efficacy or patient safety? J Clin Anesth. 1997; 9:173-178.
6. van Bastelaere M, Rolly G, Abdullah NM. Postoperative analgesia and plasma levels after transdermal fentanyl for orthopedic surgery: double-blind comparison with placebo. J Clin Anesth. 1995; 7:26-30.
7. Chelly JE, Grass J, Houseman TW, Minkowitz H, Pue A. The safety and efficacy of a fentanyl patient-controlled transdermal system for acute postoperative analgesia: a multicenter, placebo-controlled trial. Anesth Analg. 2004; 98:427-433.
8. Viscusi ER, Reynolds L, Chung F, Atkinson LE, Khanna S. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial. JAMA. 2004; 291:1333-1341.
9. Sinatra R. The fentanyl HCl patient-controlled transdermal system (PCTS): an alternative to intravenous patient-controlled analgesia in the postoperative setting. Clin Pharmacokinet. 2005; 44(suppl 1):1-6.
10. Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice - a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin. 2005; 21:1147-1156.
11. Galer BS, Gammaitoni AR, Oleka N, Jensen MP, Argoff CE. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin. 2004; 20(suppl 2):s5-s12.
12. Burch F, Codding C, Patel N, Sheldon E. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial. Osteoarthritis Cartilage. 2004; 12:253-255.
13. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003; 106:151-158.
14. Lidoderm (lidocaine transdermal) [package insert]. Chadd's Ford, Pa: Endo Pharmaceuticals; 2005.
15. Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003; 43:111-117.
16. Wheatley GH III, Rosenbaum DH, Paul MC, et al. Improved pain management outcomes with continuous infusion of a local anesthetic after thoracotomy. J Thorac Cardiovasc Surg. 2005; 130:464-468.
17. American Society of Health System Pharmacists. AHFS Drug Information. 45th ed. Bethesda, Md: American Society of Health-System Pharmacists; 2003.
18. Wong NN CJ, Luks-Golger D. Absorption of clonidine from a halved transdermal system-a pilot study. The Journal of Pharmacy Technology. 2001; 17:84-89.
19. Segal IS, Jarvis DJ, Duncan SR, White PF, Maze M. Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period. Anesthesiology. 1991; 74:220-225.
20. Owen MD, Fibuch EE, McQuillan R, Millington WR. Postoperative analgesia using a low-dose, oral-transdermal clonidine combination: lack of clinical efficacy. J Clin Anesth. 1997; 9:8-14.
21. Minitran (nitroglycerin transdermal) [package insert]. Northridge, Calif: Pharmaceuticals M; 1999.
22. Lauretti GR, de Oliveira R, Reis MP, Mattos AL, Pereira NL. Transdermal nitroglycerine enhances spinal sufentanil post-operative analgesia following orthopedic surgery. Anesthesiology. 1999; 90:734-739.
23. Lauretti GR, Oliveira A, Rodrigues AM, Paccola CA. The effect of transdermal nitroglycerin on spinal S(+)-ketamine antinociception following orthopedic surgery. J Clin Anesth. 2001; 13:576-581.
24. Transdenn Scop (scopolamine) [package insert]. Parsipanny, NJ: Novartis Consumer Health I; 2004.
25. Harris SN, Sevarino FB, Sinatra RS, Preble L, O'Connor TZ, Silverman DG. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia. Obstet Gynecol. 1991; 78:673-677.
26. Stromberg BY, Reines DH, Ackerly J. Transdermal scopolamine for the control of perioperative nausea. Am J Surg. 1991; 57:712-715.